OSBORNE PARTNERS CAPITAL MANAGEMENT, LLC historic quarter change: USA Everything Else, Reduced
In partnership units, exchange-traded notes and anything else (listed in the US), over 23 quarters from 2013-06-30 to 2026-06-30, OSBORNE PARTNERS CAPITAL MANAGEMENT, LLC opened 7 positions, added to 22, reduced 45 and sold out of 10.
- Q1 2024: Stock JPMORGAN CHASE & CO; Country of operation —; Class ALERIAN ML ETN; Shares before 427,285.
- Q3 2016: Stock T. Rowe Price Equity Income Fu; Country of operation —; Class MF; Shares before 116,503.
- Q3 2016: Stock Vanguard 500 Index; Country of operation United States; Class MF; Shares before 3,550.
- Q3 2016: Stock Fidelity Contrafund; Country of operation United States; Class MF; Shares before 4,831.
Each consecutive pair of Form 13F-HR filings compared (SEC CIK 1005607), 23 quarters: Q2 2026 (2026-03-31 to 2026-06-30, filed 2026-08-04); Q1 2026 (2025-12-31 to 2026-03-31, filed 2026-04-27); Q4 2025 (2025-09-30 to 2025-12-31, filed 2026-01-27); Q3 2025 (2025-06-30 to 2025-09-30, filed 2025-10-30); Q2 2025 (2025-03-31 to 2025-06-30, filed 2025-08-12); Q1 2025 (2024-12-31 to 2025-03-31, filed 2025-04-21); Q4 2024 (2024-09-30 to 2024-12-31, filed 2025-01-24); Q3 2024 (2024-06-30 to 2024-09-30, filed 2024-10-23); Q2 2024 (2024-03-31 to 2024-06-30, filed 2024-07-22); Q1 2024 (2023-12-31 to 2024-03-31, filed 2024-04-25); Q3 2016 (2016-06-30 to 2016-09-30, filed 2016-11-02); Q2 2016 (2016-03-31 to 2016-06-30, filed 2016-07-19); Q1 2016 (2015-12-31 to 2016-03-31, filed 2016-04-14); Q4 2015 (2015-09-30 to 2015-12-31, filed 2016-01-20); Q3 2015 (2015-06-30 to 2015-09-30, filed 2015-10-16); Q2 2015 (2015-03-31 to 2015-06-30, filed 2015-07-21); Q1 2015 (2014-12-31 to 2015-03-31, filed 2015-04-28); Q4 2014 (2014-09-30 to 2014-12-31, filed 2015-01-20); Q3 2014 (2014-06-30 to 2014-09-30, filed 2014-10-22); Q2 2014 (2014-03-31 to 2014-06-30, filed 2014-07-16); Q1 2014 (2013-12-31 to 2014-03-31, filed 2014-04-18); Q4 2013 (2013-09-30 to 2013-12-31, filed 2014-01-29); Q3 2013 (2013-06-30 to 2013-09-30, filed 2013-10-18). Rows for the same security, class and put/call are added together. Value change is the filed value at each quarter end, so it includes the price move. Only the filings held here are compared; the firm's 13F-HR filings go back to the quarter ended 1999-03-31. Not compared, as a quarter between them is not held here yet: 2016-09-30 to 2023-12-31 (missing 2016-12-31, 2017-03-31, 2017-06-30, 2017-09-30, 2017-12-31, 2018-03-31, 2018-06-30, 2018-09-30, 2018-12-31, 2019-03-31, 2019-06-30, 2019-09-30, 2019-12-31, 2020-03-31, 2020-06-30, 2020-09-30, 2020-12-31, 2021-03-31, 2021-06-30, 2021-09-30, 2021-12-31, 2022-03-31, 2022-06-30, 2022-09-30, 2022-12-31, 2023-03-31, 2023-06-30, 2023-09-30).
| Quarter | Stock | Country of operation | Class | Shares before | Shares after | Share change | Value before | Value after | Value change | Filed |
|---|
| Q1 2024 | JPMORGAN CHASE & CO
CUSIP 46625H365 | | ALERIAN ML ETN | 427,285 | 81,515 | -345,770 | $10,835,949 | $2,322,364 | -$8,513,585 | 2024-04-25 |
|---|
| Q3 2016 | T. Rowe Price Equity Income Fu
CUSIP 779547108 | | MF | 116,503 | 115,835 | -668 | $3,508,000 | $3,609,000 | +$101,000 | 2016-11-02 |
|---|
| Q3 2016 | Vanguard 500 Index
CUSIP 922908710 | United States | MF | 3,550 | 3,009 | -541 | $687,000 | $602,000 | -$85,000 | 2016-11-02 |
|---|
| Q3 2016 | Fidelity Contrafund
CUSIP 316071109 | United States | MF | 4,831 | 3,831 | -1,000 | $469,000 | $391,000 | -$78,000 | 2016-11-02 |
|---|
| Q3 2016 | T. Rowe Price Blue Chip Growth
CUSIP 77954Q106 | | MF | 7,728 | 7,528 | -200 | $527,000 | $552,000 | +$25,000 | 2016-11-02 |
|---|
| Q2 2016 | T. Rowe Price Equity Income Fu
CUSIP 779547108 | | MF | 117,313 | 116,503 | -810 | $3,418,000 | $3,508,000 | +$90,000 | 2016-07-19 |
|---|
| Q2 2016 | Longleaf Partners Small-Cap
CUSIP 543069207 | United States | MF | 28,608 | 27,747 | -861 | $807,000 | $825,000 | +$18,000 | 2016-07-19 |
|---|
| Q1 2016 | T. Rowe Price Blue Chip Growth
CUSIP 77954Q106 | | MF | 7,858 | 7,728 | -130 | $569,000 | $529,000 | -$40,000 | 2016-04-14 |
|---|
| Q1 2016 | T. Rowe Price Science & Tech
CUSIP 77957M102 | United States | MF | 6,936 | 6,296 | -640 | $238,000 | $209,000 | -$29,000 | 2016-04-14 |
|---|
| Q4 2015 | Vanguard Windsor II Admiral Sh
CUSIP 922018304 | | MF | 15,624 | 13,340 | -2,284 | $948,000 | $793,000 | -$155,000 | 2016-01-20 |
|---|
| Q4 2015 | Fidelity Contrafund
CUSIP 316071109 | United States | MF | 5,801 | 4,831 | -970 | $564,000 | $478,000 | -$86,000 | 2016-01-20 |
|---|
| Q4 2015 | T. Rowe Price Equity Income Fu
CUSIP 779547108 | | MF | 117,663 | 117,313 | -350 | $3,358,000 | $3,339,000 | -$19,000 | 2016-01-20 |
|---|
| Q4 2015 | Longleaf Partners Small-Cap
CUSIP 543069207 | United States | MF | 29,508 | 28,608 | -900 | $788,000 | $772,000 | -$16,000 | 2016-01-20 |
|---|
| Q3 2015 | T. Rowe Price Equity Income Fu
CUSIP 779547108 | | MF | 118,062 | 117,663 | -399 | $3,778,000 | $3,358,000 | -$420,000 | 2015-10-16 |
|---|
| Q3 2015 | T. Rowe Price Science & Tech
CUSIP 77957M102 | United States | MF | 8,939 | 6,936 | -2,003 | $349,000 | $248,000 | -$101,000 | 2015-10-16 |
|---|
| Q3 2015 | Travelcenters of America, LLC
CUSIP JKE174103 | | PRD | 180,000 | 90,000 | -90,000 | $0 | $0 | $0 | 2015-10-16 |
|---|
| Q2 2015 | T. Rowe Price Equity Income Fu
CUSIP 779547108 | | MF | 118,718 | 118,062 | -656 | $3,841,000 | $3,778,000 | -$63,000 | 2015-07-21 |
|---|
| Q2 2015 | Longleaf Partners Small-Cap
CUSIP 543069207 | United States | MF | 30,095 | 29,508 | -587 | $970,000 | $939,000 | -$31,000 | 2015-07-21 |
|---|
| Q2 2015 | Vanguard Windsor II Admiral Sh
CUSIP 922018304 | | MF | 15,924 | 15,624 | -300 | $1,053,000 | $1,033,000 | -$20,000 | 2015-07-21 |
|---|
| Q2 2015 | T. Rowe Price Science & Tech
CUSIP 77957M102 | United States | MF | 9,247 | 8,939 | -308 | $357,000 | $349,000 | -$8,000 | 2015-07-21 |
|---|
| Q1 2015 | T. Rowe Price Equity Income Fu
CUSIP 779547108 | | MF | 121,015 | 118,718 | -2,297 | $3,969,000 | $3,841,000 | -$128,000 | 2015-04-28 |
|---|
| Q1 2015 | Longleaf Partners Small-Cap
CUSIP 543069207 | United States | MF | 30,758 | 30,095 | -663 | $936,000 | $970,000 | +$34,000 | 2015-04-28 |
|---|
| Q1 2015 | Vanguard Windsor II Admiral Sh
CUSIP 922018304 | | MF | 16,308 | 15,924 | -384 | $1,080,000 | $1,053,000 | -$27,000 | 2015-04-28 |
|---|
| Q1 2015 | T. Rowe Price Science & Tech
CUSIP 77957M102 | United States | MF | 9,522 | 9,247 | -275 | $356,000 | $357,000 | +$1,000 | 2015-04-28 |
|---|
| Q4 2014 | Vanguard Windsor II Admiral Sh
CUSIP 922018304 | | MF | 19,108 | 16,308 | -2,800 | $1,323,000 | $1,080,000 | -$243,000 | 2015-01-20 |
|---|
| Q4 2014 | Longleaf Partners Small-Cap
CUSIP 543069207 | United States | MF | 31,500 | 30,758 | -742 | $1,108,000 | $936,000 | -$172,000 | 2015-01-20 |
|---|
| Q4 2014 | T. Rowe Price Equity Income Fu
CUSIP 779547108 | | MF | 121,025 | 121,015 | -10 | $4,087,000 | $3,969,000 | -$118,000 | 2015-01-20 |
|---|
| Q4 2014 | Federated Strategic Value Divi
CUSIP 314172560 | | MF | 29,796 | 23,320 | -6,476 | $183,000 | $138,000 | -$45,000 | 2015-01-20 |
|---|
| Q3 2014 | T. Rowe Price Equity Income Fu
CUSIP 779547108 | | MF | 122,192 | 121,025 | -1,167 | $4,214,000 | $4,087,000 | -$127,000 | 2014-10-22 |
|---|
| Q2 2014 | T. Rowe Price Science & Tech
CUSIP 77957M102 | United States | MF | 12,316 | 9,522 | -2,794 | $493,000 | $399,000 | -$94,000 | 2014-07-16 |
|---|
| Q2 2014 | Longleaf Partners Small-Cap
CUSIP 543069207 | United States | MF | 31,991 | 31,500 | -491 | $1,092,000 | $1,117,000 | +$25,000 | 2014-07-16 |
|---|
| Q2 2014 | Vanguard 500 Index
CUSIP 922908496 | | MF | 3,643 | 3,009 | -634 | $520,000 | $544,000 | +$24,000 | 2014-07-16 |
|---|
| Q2 2014 | Wells Fargo VT Advantage Oppor
CUSIP 949756845 | | MF | 15,858 | 15,644 | -214 | $266,000 | $275,000 | +$9,000 | 2014-07-16 |
|---|
| Q2 2014 | DWS Dreman Small Mid Cap Val V
CUSIP 23338H750 | | MF | 10,149 | 10,012 | -137 | $161,000 | $166,000 | +$5,000 | 2014-07-16 |
|---|
| Q1 2014 | T. Rowe Price Equity Income Fu
CUSIP 779547108 | | MF | 128,058 | 120,841 | -7,217 | $4,205,000 | $4,007,000 | -$198,000 | 2014-04-18 |
|---|
| Q1 2014 | Longleaf Partners Small-Cap
CUSIP 543069207 | United States | MF | 35,532 | 31,991 | -3,541 | $1,153,000 | $1,092,000 | -$61,000 | 2014-04-18 |
|---|
| Q1 2014 | T. Rowe Price Science & Tech
CUSIP 77957M102 | United States | MF | 12,391 | 12,316 | -75 | $484,000 | $493,000 | +$9,000 | 2014-04-18 |
|---|
| Q1 2014 | Wells Fargo VT Advantage Oppor
CUSIP 949756845 | | MF | 16,081 | 15,858 | -223 | $263,000 | $266,000 | +$3,000 | 2014-04-18 |
|---|
| Q1 2014 | DWS Dreman Small Mid Cap Val V
CUSIP 23338H750 | | MF | 10,291 | 10,149 | -142 | $163,000 | $161,000 | -$2,000 | 2014-04-18 |
|---|
| Q4 2013 | Longleaf Partners Small-Cap
CUSIP 543069207 | United States | MF | 38,532 | 35,532 | -3,000 | $1,374,000 | $1,153,000 | -$221,000 | 2014-01-29 |
|---|
| Q4 2013 | T. Rowe Price Equity Income Fu
CUSIP 779547108 | | MF | 129,530 | 128,058 | -1,472 | $4,035,000 | $4,205,000 | +$170,000 | 2014-01-29 |
|---|
| Q4 2013 | Fidelity Equity Income II
CUSIP 316145101 | | MF | 18,368 | 18,159 | -209 | $419,000 | $447,000 | +$28,000 | 2014-01-29 |
|---|
| Q4 2013 | Wells Fargo VT Advantage Oppor
CUSIP 949756845 | | MF | 18,613 | 16,081 | -2,532 | $278,000 | $263,000 | -$15,000 | 2014-01-29 |
|---|
| Q3 2013 | T. Rowe Price Equity Income Fu
CUSIP 779547108 | | MF | 130,892 | 129,530 | -1,362 | $3,916,000 | $4,035,000 | +$119,000 | 2013-10-18 |
|---|
| Q3 2013 | Longleaf Partners Small-Cap
CUSIP 543069207 | United States | MF | 38,909 | 38,532 | -377 | $1,291,000 | $1,374,000 | +$83,000 | 2013-10-18 |
|---|